Delivery Order SPE2DB24D2212-SPE2DB25FHQSD
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,244.93 to AmerisourceBergen Drug Corp for the supply of Duloxetine HCL DR 60 mg capsules (1,000 units). This competitively awarded, firm fixed-price delivery order was issued on August 21, 2025, with an ultimate completion date of August 22, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. Duloxetine is a serotonin-norepinephrine reuptake...
- The Defense Logistics Agency awarded a delivery order valued at $8,659.63 to AmerisourceBergen Drug Corp for 1,000 capsules of Duloxetine HCL DR 60 mg, with an ultimate completion date of September 2, 2025. This firm fixed-price delivery order, issued on August 29, 2025, was not set-aside and represents a competitive award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 and extending through December...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of 1,000 units of Duloxetine HCL DR 60 mg capsules at a ceiling value of $1,433.94. This is a firm fixed-price delivery order with an ultimate completion date of August 26, 2025, and represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $2,219.33 to AmerisourceBergen Drug Corp for 1,000 capsules of Duloxetine HCL DR 20 mg, with performance completion scheduled for August 28, 2025. This non-set-aside, competitively awarded contract uses firm fixed pricing and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. Duloxetine is a serotonin-norepinephrine reuptake inhibitor (SNRI) commonly used to treat depression, anxiety, and chronic pain...
- This delivery order, awarded on August 28, 2025, by the Defense Logistics Agency's Medical Supply Chain to AmerisourceBergen Drug Corp, provides 1,000 capsules of Duloxetine HCl 60 mg under a firm fixed-price contract valued at $2,247.82. The order will be completed by August 29, 2025, and performed at the contractor's Conshohocken, Pennsylvania facility. This award represents a non-competitive delivery order issued against AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency valued at $3,022.92 for 1,000 capsules of Duloxetine HCL DR 60 mg. The award, issued on August 20, 2025, with an ultimate completion date of August 21, 2025, carries a firm fixed price and was competitively awarded with no set-aside designation. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,434.93 to AmerisourceBergen Drug Corp for 1,000 units of Duloxetine HCL DR 60 mg capsules, with an ultimate completion date of August 20, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and...
- The Defense Logistics Agency awarded a delivery order valued at $1,084.80 to AmerisourceBergen Drug Corp for Duloxetine HCL DR 40 mg capsules (30-count) on August 15, 2025, with completion expected by August 18, 2025. This firm fixed-price, non-set-aside contract is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. As a child order under a larger contract vehicle, this delivery order represents a routine pharmaceutical procurement fulfilling federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $3,376.36 to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Duloxetine HCL DR 40 mg capsules (30-count units). This contract utilizes a firm fixed-price structure and is not set aside for any particular business category. The award is classified as a delivery order, indicating it derives from an existing indefinite delivery contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Duloxetine HCL DR 40 mg capsules (30-count packaging) with a ceiling value of $1,882.44. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and carries an ultimate completion date of August 29, 2025. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DB24D2212Indefinite Delivery Contract
- SPE2DB24D2212-SPE2DB25FHQSDDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Duloxetine HCL DR 60 mg capsules (1,000 count) valued at $2,115.10. The contract is a firm fixed price delivery order with an ultimate completion date of September 3, 2025, and was awarded on a competitive basis without set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle running through December 2026. Duloxetine is a serotonin-norepinephrine reuptake inhibitor commonly used for the treatment of major depressive disorder, anxiety disorders, and chronic pain conditions. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor that supplies the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems with a comprehensive range of pharmaceutical products, medical supplies, vaccines, and specialty medications to support military and veteran healthcare needs. The company's consistent success in competing for federal pharmaceutical contracts demonstrates its capability to meet stringent federal procurement requirements and supply chain standards.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 9/2/25 |